PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 23458898-5 2013 LET-19/MDT-13 is part of the CDK8 module of the Mediator. mdt 7-10 Mediator of RNA polymerase II transcription subunit 13 Caenorhabditis elegans 0-6 25478165-4 2014 The bioorthogonal Staudinger ligation scheme was used to chemoselectively crosslink azide functionalized hyperbranched alginate (alginate-hN3) to methyl-2-diphenylphosphino-terephthalate (MDT) linked PAMAM dendrimer (PAMAM-MDT). mdt 188-191 MT-RNR2 like 3 (pseudogene) Homo sapiens 138-141 25113575-8 2014 The reaction of [PdCl2(PPh3)2] with Li2(mdt) produced a mixture of [Pd(mdt)(PPh3)2] (12, 20%) and [(Ph3P)Pd(mu-1,2-mdt-S,S":S)2Pd(PPh3)] (13, 28%), with the latter having C2 symmetry with a Pd2S2 core structure folded along the S S axis. mdt 40-43 caveolin 1 Homo sapiens 23-27 25113575-8 2014 The reaction of [PdCl2(PPh3)2] with Li2(mdt) produced a mixture of [Pd(mdt)(PPh3)2] (12, 20%) and [(Ph3P)Pd(mu-1,2-mdt-S,S":S)2Pd(PPh3)] (13, 28%), with the latter having C2 symmetry with a Pd2S2 core structure folded along the S S axis. mdt 40-43 caveolin 1 Homo sapiens 76-80 25113575-8 2014 The reaction of [PdCl2(PPh3)2] with Li2(mdt) produced a mixture of [Pd(mdt)(PPh3)2] (12, 20%) and [(Ph3P)Pd(mu-1,2-mdt-S,S":S)2Pd(PPh3)] (13, 28%), with the latter having C2 symmetry with a Pd2S2 core structure folded along the S S axis. mdt 40-43 caveolin 1 Homo sapiens 76-80 24465659-6 2014 In addition, CAT activity was significantly reduced in MDT-treated leprosy patients, while GSH content was increased in these patients. mdt 55-58 catalase Homo sapiens 13-16 23458898-5 2013 LET-19/MDT-13 is part of the CDK8 module of the Mediator. mdt 7-10 Cyclin-dependent kinase 8 Caenorhabditis elegans 29-33 35016990-3 2022 The expression of the signature Treg molecule Foxp3, interleukin-10 (IL-10), transforming growth factor-beta (TGF-beta), and interferon regulatory factor 4 (IRF-4) in patients with DFU treated with or without MDT was tested by real-time PCR (RT-PCR). mdt 209-212 interferon regulatory factor 4 Homo sapiens 157-162 11815725-9 2001 The mean GH level of 21 boys who received MDT was increased from 5.38 +/- 2.50 ng/ml (by priming with one dose T) to 10.19 +/- 6.13 ng/ml (p = 0.004). mdt 42-45 growth hormone 1 Homo sapiens 9-11 11815725-15 2001 The ones who failed in GH stimulation tests after one dose T injection can be primed with MDT. mdt 90-93 growth hormone 1 Homo sapiens 23-25 22340540-6 2012 RESULTS: The number of examined lymph nodes and the accuracy of TNM staging by CT in the MDT group were significantly more than those in pre-MDT group. mdt 89-92 teneurin transmembrane protein 1 Homo sapiens 64-67 22340540-7 2012 CT TNM staging was more accurate in the MDT group compared to the pre-MDT group (P = 0.044). mdt 40-43 teneurin transmembrane protein 1 Homo sapiens 3-6 21273376-14 2011 This occurred despite a lack of significant differences for secondary disease-specific measures, suggesting that other differences in the MDT population or care process accounted for the slower decline in GFR in the MDT group. mdt 138-141 Rap guanine nucleotide exchange factor 5 Homo sapiens 205-208 10206118-8 1999 Soluble ICAM-1 levels decreased in the MDT group but did not change in the MDT + IFN-gamma treated patients. mdt 39-42 intercellular adhesion molecule 1 Homo sapiens 8-14 10206118-10 1999 Neopterin, a marker of macrophage activation, increased in all but one patient treated with MDT + IFN-gamma but in none treated with MDT alone, indicating that IFN-gamma was active in vivo. mdt 92-95 interferon gamma Homo sapiens 160-169 2376683-4 1990 Treatment of effectors with IL-2 or IFN-alpha enhanced NK cytotoxicity in 5 of 6 untreated LL patients, 6 of 6 treated MDT-R LL patients, 4 of 5 and 3 of 5 treated MDT-NR LL patients, respectively, and 5 of 8 and 3 of 8 treated TT patients, respectively. mdt 119-122 interleukin 2 Homo sapiens 28-32 2376683-4 1990 Treatment of effectors with IL-2 or IFN-alpha enhanced NK cytotoxicity in 5 of 6 untreated LL patients, 6 of 6 treated MDT-R LL patients, 4 of 5 and 3 of 5 treated MDT-NR LL patients, respectively, and 5 of 8 and 3 of 8 treated TT patients, respectively. mdt 119-122 interferon alpha 1 Homo sapiens 36-45 2376683-4 1990 Treatment of effectors with IL-2 or IFN-alpha enhanced NK cytotoxicity in 5 of 6 untreated LL patients, 6 of 6 treated MDT-R LL patients, 4 of 5 and 3 of 5 treated MDT-NR LL patients, respectively, and 5 of 8 and 3 of 8 treated TT patients, respectively. mdt 164-167 interleukin 2 Homo sapiens 28-32 2376683-4 1990 Treatment of effectors with IL-2 or IFN-alpha enhanced NK cytotoxicity in 5 of 6 untreated LL patients, 6 of 6 treated MDT-R LL patients, 4 of 5 and 3 of 5 treated MDT-NR LL patients, respectively, and 5 of 8 and 3 of 8 treated TT patients, respectively. mdt 164-167 interferon alpha 1 Homo sapiens 36-45 35388442-8 2022 ROC analysis revealed a cut-off of <=3 metastatic lesions on PSMA-PET for the steering of treatment decisions towards MDT rather than solely systemic therapy (AUC: 0.88). mdt 118-121 folate hydrolase 1 Homo sapiens 61-65 35016990-5 2022 RESULTS: Foxp3 expression was obviously increased in DFU patients treated using MDT but less pronounced in those treated without MDT (P < 0.05). mdt 80-83 forkhead box P3 Homo sapiens 9-14 35016990-5 2022 RESULTS: Foxp3 expression was obviously increased in DFU patients treated using MDT but less pronounced in those treated without MDT (P < 0.05). mdt 129-132 forkhead box P3 Homo sapiens 9-14 35016990-6 2022 Foxp3, IL-10, TGF-beta, and IRF-4 gene expression levels were higher in DFU patients treated with MDT than in those treated without MDT. mdt 98-101 forkhead box P3 Homo sapiens 0-5 35016990-6 2022 Foxp3, IL-10, TGF-beta, and IRF-4 gene expression levels were higher in DFU patients treated with MDT than in those treated without MDT. mdt 98-101 interleukin 10 Homo sapiens 7-12 35016990-6 2022 Foxp3, IL-10, TGF-beta, and IRF-4 gene expression levels were higher in DFU patients treated with MDT than in those treated without MDT. mdt 98-101 transforming growth factor alpha Homo sapiens 14-22 35016990-6 2022 Foxp3, IL-10, TGF-beta, and IRF-4 gene expression levels were higher in DFU patients treated with MDT than in those treated without MDT. mdt 98-101 interferon regulatory factor 4 Homo sapiens 28-33 35016990-6 2022 Foxp3, IL-10, TGF-beta, and IRF-4 gene expression levels were higher in DFU patients treated with MDT than in those treated without MDT. mdt 132-135 forkhead box P3 Homo sapiens 0-5 35016990-6 2022 Foxp3, IL-10, TGF-beta, and IRF-4 gene expression levels were higher in DFU patients treated with MDT than in those treated without MDT. mdt 132-135 interferon regulatory factor 4 Homo sapiens 28-33 33685838-16 2021 CONCLUSIONS: PSMA-defined oligorecurrent-PCa can be rendered bNED, a necessary step towards cure, in 1 of 5 patients receiving MDT alone. mdt 127-130 folate hydrolase 1 Homo sapiens 13-17 33238687-6 2020 Western blotting and real-time fluorescent quantitative reverse transcription polymerase chain reaction (RT-PCR) were used respectively to detect the protein and mRNA expressions of fatty acid synthase (FAS) in wound tissue of patients in DFU group before and after application of MDT and in non-diabetic trauma group before debridement. mdt 281-284 fatty acid synthase Homo sapiens 182-201 33238687-6 2020 Western blotting and real-time fluorescent quantitative reverse transcription polymerase chain reaction (RT-PCR) were used respectively to detect the protein and mRNA expressions of fatty acid synthase (FAS) in wound tissue of patients in DFU group before and after application of MDT and in non-diabetic trauma group before debridement. mdt 281-284 fatty acid synthase Homo sapiens 203-206 33238687-19 2020 Results: (1) Compared with those before application of MDT, fresh granulation tissue significantly increased and necrotic tissue decreased obviously in wound, and the expression of CD31 significantly increased in wound tissue of patients in DFU group after application of MDT. mdt 55-58 platelet and endothelial cell adhesion molecule 1 Homo sapiens 181-185 33238687-19 2020 Results: (1) Compared with those before application of MDT, fresh granulation tissue significantly increased and necrotic tissue decreased obviously in wound, and the expression of CD31 significantly increased in wound tissue of patients in DFU group after application of MDT. mdt 272-275 platelet and endothelial cell adhesion molecule 1 Homo sapiens 181-185 33238687-22 2020 The expression of FAS mRNA in wound tissue of patients in DFU group after application of MDT was 1.85+-0.31, which was significantly higher than that before application of MDT (t=-10.853, P<0.01). mdt 89-92 fatty acid synthase Homo sapiens 18-21 33238687-22 2020 The expression of FAS mRNA in wound tissue of patients in DFU group after application of MDT was 1.85+-0.31, which was significantly higher than that before application of MDT (t=-10.853, P<0.01). mdt 172-175 fatty acid synthase Homo sapiens 18-21 28639355-9 2018 MDT, influenced by other DAP characteristics (co-location of staff, patient navigators, team functioning), may also influence service delivery. mdt 0-3 death associated protein Homo sapiens 25-28